Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | -5.56% | 0.00% | -15.00% |
10/04 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
10/04 | Telo Genomics Corp. Receives Accreditation from College of American Pathologists | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 20.99M 28.69M 1.75B |
---|---|---|---|---|---|
Net income 2022 | -2M -2.73M -167M | Net income 2023 | -2M -2.73M -167M | EV / Sales 2022 | - |
Net cash position 2022 | 2.65M 3.63M 221M | Net cash position 2023 | 2.64M 3.61M 220M | EV / Sales 2023 | - |
P/E ratio 2022 |
-9.95
x | P/E ratio 2023 |
-6.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.41% |
1 day | -5.56% | ||
Current month | +47.83% | ||
1 month | +41.67% | ||
3 months | +6.25% | ||
6 months | -20.93% | ||
Current year | -15.00% |
Managers | Title | Age | Since |
---|---|---|---|
Kris Weinberg
CEO | Chief Executive Officer | - | 12/22/12 |
Sherif Louis
PSD | President | - | 01/15/01 |
Christopher Ross
DFI | Director of Finance/CFO | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Meekison
BRD | Director/Board Member | 58 | 27/20/27 |
Director/Board Member | - | 03/22/03 | |
Guido Baechler
CHM | Chairman | 59 | 28/19/28 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.17 | -5.56% | 233,000 |
24/24/24 | 0.18 | +5.88% | 32,000 |
23/24/23 | 0.17 | -17.07% | 106,003 |
22/24/22 | 0.205 | +20.59% | 23,911 |
19/24/19 | 0.17 | -17.07% | 33,677 |
Delayed Quote Toronto S.E., April 27, 2024 at 01:27 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-15.00% | 8.86M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- TELO Stock